Question 1

What is Alto Neuroscience?

Accepted Answer

Alto Neuroscience is a Company.

Question 2

How often does Alto Neuroscience appear in global news?

Accepted Answer

Tracked across 5 news events drawn from 31 articles.

Question 3

When was Alto Neuroscience first tracked by Ergen?

Accepted Answer

First tracked on Jul 25, 2025.

Question 4

When was Alto Neuroscience last mentioned in news?

Accepted Answer

Last active on May 29, 2026.

Question 5

What is Alto Neuroscience's current news sentiment?

Accepted Answer

Aggregate sentiment score: -40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Alto Neuroscience in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 5 events.

Question 7

What is the most recent event involving Alto Neuroscience?

Accepted Answer

Alto Neuroscience Securities Fraud Lawsuit (Jul 29, 2025, 6 articles).

Question 8

How did the "Alto Neuroscience Securities Fraud Lawsuit" event impact Alto Neuroscience?

Accepted Answer

Alto Neuroscience is facing a federal securities class action lawsuit due to allegedly misleading statements regarding the effectiveness of its drug ALTO-100 for MDD, which led to a significant drop in its stock price.

Question 9

How did the "Alto Neuroscience faces securities fraud lawsuit" event impact Alto Neuroscience?

Accepted Answer

Alto Neuroscience is the target of a class action lawsuit alleging securities fraud due to misstatements about the effectiveness of its product pipeline, ALTO-100, and its financial prospects.

Question 10

How did the "Alto Neuroscience Class Action Lawsuit" event impact Alto Neuroscience?

Accepted Answer

Alto Neuroscience is facing a class action lawsuit for allegedly making false and misleading statements regarding the effectiveness of its drug ALTO-100 for major depressive disorder, which could lead to significant financial and reputational damage.

Question 11

How did the "MIT Links grin2a Gene to Schizophrenia" event impact Alto Neuroscience?

Accepted Answer

Alto Neuroscience is the journal where the new study was published.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.